Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: A meta-analysis of published studies

被引：0
|
作者：
Lin, Gang [1 ]
Han, Shuiyun [1 ]
Mao, Weimin [1 ]
Xu, Yaping [1 ]
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e15044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15044
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant chemoradiotherapy, chemotherapy, and radiotherapy do not significantly increase the incidence of anastomotic leakage after esophageal cancer surgery: a meta-analysis
    Jin, Zixian
    Zhang, Jian
    Chen, Dong
    Wu, Sikai
    Xue, Penglai
    Zhu, Kanghao
    Xu, Congcong
    Zhu, Chengchu
    Zhang, Bo
    DISEASES OF THE ESOPHAGUS, 2022, 35 (09)
  • [32] Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis
    Fan, Mengying
    Lin, Yao
    Pan, Jianhong
    Yan, Wanpu
    Dai, Liang
    Shen, Luyan
    Chen, Keneng
    THORACIC CANCER, 2016, 7 (02) : 173 - 181
  • [33] Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis
    Wang, Dong-Bin
    Sun, Zhong-Yi
    Deng, Li-Min
    Zhu, De-Qing
    Xia, Hong-Gang
    Zhu, Peng-Zhi
    CHINESE MEDICAL JOURNAL, 2016, 129 (24) : 2974 - 2982
  • [34] Neoadjuvant Chemoradiotherapy Could Improve Survival Outcomes for Esophageal Carcinoma: A Meta-Analysis
    Dong-Bin Wang
    Xun Zhang
    Hong-Li Han
    Yi-Jun Xu
    Da-Qiang Sun
    Zhen-Liang Shi
    Digestive Diseases and Sciences, 2012, 57 : 3226 - 3233
  • [35] Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis
    Wang DongBin
    Sun ZhongYi
    Deng LiMin
    Zhu DeQing
    Xia HongGang
    Zhu PengZhi
    Department of Cardiothoracic Surgery Tianjin Hospital Tianjin China
    中华医学杂志英文版, 2016, 129 (24) : 2974 - 2982
  • [36] Neoadjuvant Chemoradiotherapy Could Improve Survival Outcomes for Esophageal Carcinoma: A Meta-Analysis
    Wang, Dong-Bin
    Zhang, Xun
    Han, Hong-Li
    Xu, Yi-Jun
    Sun, Da-Qiang
    Shi, Zhen-Liang
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (12) : 3226 - 3233
  • [37] Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer A Systematic Review and Meta-analysis
    Eyck, Ben M.
    Onstenk, Barbera D.
    Noordman, Bo J.
    Nieboer, Daan
    Spaander, Manon C. W.
    Valkema, Roelf
    Lagarde, Sjoerd M.
    Wijnhoven, Bas P. L.
    van Lanschot, J. Jan B.
    ANNALS OF SURGERY, 2020, 271 (02) : 245 - 256
  • [38] Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis
    Liu, Yunsong
    Bao, Yongxing
    Yang, Xu
    Sun, Shuang
    Yuan, Meng
    Ma, Zeliang
    Zhang, Wanting
    Zhai, Yirui
    Wang, Yang
    Men, Yu
    Qin, Jianjun
    Xue, Liyan
    Wang, Jun
    Hui, Zhouguang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [39] Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies
    Tomasello, G.
    Petrelli, F.
    Ghidini, M.
    Pezzica, E.
    Passalacqua, R.
    Steccanella, F.
    Turati, L.
    Sgroi, G.
    Barni, S.
    EJSO, 2017, 43 (09): : 1607 - 1616
  • [40] Interval Between Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma: Does Delayed Surgery Impact Outcome?
    Chiu, Chien-Hong
    Chao, Yin-Kai
    Chang, Hsien-Kun
    Tseng, Chen-Kan
    Chan, Sheng-Chieh
    Liu, Yun-Hen
    Chen, Wei-Hsun
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (13) : 4245 - 4251
12345